Arkolith/Insider Trading/RSLS/Form 4

Stankovich Thomas

Chief Financial OfficerReShape Lifesciences Inc. (RSLS) · full profile →Form 4 · filed Nov 18, 2021
Net Buying
Open-Market Buys
$40K
Open-Market Sells
$0
Net Open-Market Flow
$40K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2021Buy(P)20K$2.02$40K370K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001235802-21-000132) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML